CDSCO UID IMP/MD/2018/000223_fa0d7112604d4bb8d4395443dbc6322d_fb29d4af6db8a4c60f89424e9d73f632Lactate Dehydrogenase2
- UID
- IMP/MD/2018/000223_fa0d7112604d4bb8d4395443dbc6322d_fb29d4af6db8a4c60f89424e9d73f632
- Device class
- Class B
- Brand name
- ARCHTECT Total T4 Controls
- License holder
- Abbott Healthcare Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The Lactate Dehydrogenase2 assay is used for the quantitation of lactate dehydrogenase (ARCHTECT Total T4 Controls) in human serum or plasma on the Alinity c system
Lactate Dehydrogenase2 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000223_fa0d7112604d4bb8d4395443dbc6322d_fb29d4af6db8a4c60f89424e9d73f632. This device is marketed under the brand name ARCHTECT Total T4 Controls. The license holder is Abbott Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.